211 related articles for article (PubMed ID: 32890024)
1. Embryonal tumors of the central nervous system.
Pagès M; Masliah-Planchon J; Bourdeaut F
Curr Opin Oncol; 2020 Nov; 32(6):623-630. PubMed ID: 32890024
[TBL] [Abstract][Full Text] [Related]
2. Embryonal Tumors of the Central Nervous System: An Update.
Blessing MM; Alexandrescu S
Surg Pathol Clin; 2020 Jun; 13(2):235-247. PubMed ID: 32389264
[TBL] [Abstract][Full Text] [Related]
3. Embryonal Tumors of the Central Nervous System: From the Radiologic Pathology Archives.
Shih RY; Koeller KK
Radiographics; 2018; 38(2):525-541. PubMed ID: 29528832
[TBL] [Abstract][Full Text] [Related]
4. Embryonal Tumors of the Central Nervous System with Multilayered Rosettes and Atypical Teratoid/Rhabdoid Tumors.
Kamenova M; Kaneva R; Genova K; Gabrovsky N
Adv Exp Med Biol; 2023; 1405():225-252. PubMed ID: 37452940
[TBL] [Abstract][Full Text] [Related]
5. Practical molecular pathology and histopathology of embryonal tumors.
Phillips J; Tihan T; Fuller G
Surg Pathol Clin; 2015 Mar; 8(1):73-88. PubMed ID: 25783823
[TBL] [Abstract][Full Text] [Related]
6. Embryonal tumors in the WHO CNS5 classification: A Review.
Gianno F; Miele E; Antonelli M; Giangaspero F
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
[TBL] [Abstract][Full Text] [Related]
7. Current Open Trials and Molecular Update for Pediatric Embryonal Tumors.
Rosenberg T; Cooney T
Pediatr Neurosurg; 2023; 58(5):299-306. PubMed ID: 37245504
[TBL] [Abstract][Full Text] [Related]
8. Histopathologic and Molecular Features of Central Nervous System Embryonal Tumors for Integrated Diagnosis Reporting.
Cole BL; Pierson CR
Surg Pathol Clin; 2020 Dec; 13(4):783-800. PubMed ID: 33183733
[TBL] [Abstract][Full Text] [Related]
9. Aggressive infantile embryonal tumors.
MacDonald TJ
J Child Neurol; 2008 Oct; 23(10):1195-204. PubMed ID: 18952586
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of Outcomes by Treatment Regimen and Histology in Central Nervous System Primary Embryonal Tumors.
Bhimani AD; Ryoo JS; Reddy AK; Denyer S; McGuire LS; Alonso M; Mehta AI
World Neurosurg; 2020 Sep; 141():e289-e306. PubMed ID: 32434022
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics of atypical teratoid/rhabdoid tumor.
Oka H; Scheithauer BW
Neurol Med Chir (Tokyo); 1999 Jul; 39(7):510-7; discussion 517-8. PubMed ID: 10437379
[TBL] [Abstract][Full Text] [Related]
12. Ependymoblastoma: dear, damned, distracting diagnosis, farewell!*.
Judkins AR; Ellison DW
Brain Pathol; 2010 Jan; 20(1):133-9. PubMed ID: 19120373
[TBL] [Abstract][Full Text] [Related]
13. Atypical teratoid/rhabdoid tumors of the central nervous system.
Reddy AT
J Neurooncol; 2005 Dec; 75(3):309-13. PubMed ID: 16195799
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors.
Han YP; Ma CK; Wang SQ; Enomoto A; Zhao Y; Takahashi M; Ma J
J Neurooncol; 2014 Sep; 119(2):343-51. PubMed ID: 24879375
[TBL] [Abstract][Full Text] [Related]
15. Embryonal tumors in Canadian children less than 36 months of age: results from the Canadian Pediatric Brain Tumor Consortium (CPBTC).
Story E; Johnston DL; Bartels U; Carret AS; Crooks B; Eisenstat DD; Fryer C; Lafay-Cousin L; Larouche V; Wilson B; Zelcer S; Silva M; Brossard J; Bouffet E; Keene DL
J Neurooncol; 2017 Jul; 133(3):581-587. PubMed ID: 28508928
[TBL] [Abstract][Full Text] [Related]
16. Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET.
Garcia-Moure M; Gonzalez-Huarriz M; Labiano S; Guruceaga E; Bandres E; Zalacain M; Marrodan L; de Andrea C; Villalba M; Martinez-Velez N; Laspidea V; Puigdelloses M; Gallego Perez-Larraya J; Iñigo-Marco I; Stripecke R; Chan JA; Raabe EH; Kool M; Gomez-Manzano C; Fueyo J; Patiño-García A; Alonso MM
Clin Cancer Res; 2021 Mar; 27(6):1807-1820. PubMed ID: 33376098
[TBL] [Abstract][Full Text] [Related]
17. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.
Tekautz TM; Fuller CE; Blaney S; Fouladi M; Broniscer A; Merchant TE; Krasin M; Dalton J; Hale G; Kun LE; Wallace D; Gilbertson RJ; Gajjar A
J Clin Oncol; 2005 Mar; 23(7):1491-9. PubMed ID: 15735125
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
[TBL] [Abstract][Full Text] [Related]
19. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017.
Niehusmann P; Stensvold E; Leske H; Pietsch T; Goschzik T; Gielen GH; Due-Tønnessen B; Frič R; Nilssen Y; Brandal P
Pediatr Blood Cancer; 2022 Sep; 69(9):e29736. PubMed ID: 35570402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]